IGF2BP3 promotes the progression of gastric cancer by activating cGMP-PKG signaling pathway via targeting FBXO32
Yi Si, Bo Tian, Rui Zhang, Mingda Xuan, Kunyi Liu, Jiao Jiao, Shuangshuang Han, Hongfei Li, Yanhong Hu, Hongyan Zhao, Wenjing He, Jia Wang, Ting Liu, Weifang Yu
This study identifies IGF2BP3 as a promoter of gastric cancer progression by upregulating FBXO32 via m6A binding and activating the cGMP-PKG signaling pathway.
World Journal of Gastroenterology · Dec 10, 2025Peer-reviewedCancer Biology